MDM2 and prostate cancer: Anti-androgens induce FBW7 and MDM2 transcripts and promote the degradation of a target ion channel KCa1.1; ARs will likely also be subject to ubiquitin-mediated degradation as it is a target for the Ub-E3 activity of MDM2 in prostate cancer [68].